VOYA Investment Management’s Travere Therapeutics TVTX Stock Holding History

VOYA Investment Management’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.84M	Buy	196,541 +40,646	+26%	+$1.22M	0.01%	779
2025 Q4	$5.96M	Sell	155,895 -38,959	-20%	-$1.27M	0.01%	802
2025 Q3	$4.66M	Buy	194,854 +27,133	+16%	+$510K	﹤0.01%	899
2025 Q2	$2.48M	Buy	167,721 +44,812	+36%	+$743K	﹤0.01%	1214
2025 Q1	$2.2M	Sell	122,909 -76,763	-38%	-$1.56M	﹤0.01%	1272
2024 Q4	$3.48M	Sell	199,672 -22,798	-10%	-$403K	﹤0.01%	1089
2024 Q3	$3.11M	Buy	222,470 +197,528	+792%	+$2.06M	﹤0.01%	1193
2024 Q2	$205K	Sell	24,942 -182,840	-88%	-$1.23M	﹤0.01%	2461
2024 Q1	$1.6M	Buy	207,782 +178,402	+607%	+$1.51M	﹤0.01%	1430
2023 Q4	$264K	Sell	29,380 -18,595	-39%	-$135K	﹤0.01%	2423
2023 Q3	$429K	Buy	47,975 +569	+1%	+$8.03K	﹤0.01%	2121
2023 Q2	$728K	Buy	47,406 +5,389	+13%	+$98K	﹤0.01%	1866
2023 Q1	$945K	Hold	42,017	–	–	﹤0.01%	1680
2022 Q4	$884K	Sell	42,017 -1,330	-3%	-$28.2K	﹤0.01%	1706
2022 Q3	$1.07M	Sell	43,347 -45,635	-51%	-$1.18M	﹤0.01%	1599
2022 Q2	$2.15M	Buy	88,982 +65,560	+280%	+$1.65M	0.01%	1078
2022 Q1	$604K	Buy	23,422 +409	+2%	+$10.9K	﹤0.01%	1793
2021 Q4	$715K	Sell	23,013 -291	-1%	-$8.2K	﹤0.01%	1778
2021 Q3	$565K	Sell	23,304 -20	-0.1%	-$367	﹤0.01%	1983
2021 Q2	$341K	Buy	23,324 +317	+1%	+$6.25K	﹤0.01%	2315
2021 Q1	$574K	Buy	23,007 +977	+4%	+$27K	﹤0.01%	1949
2020 Q4	$600K	Buy	22,030 +6,620	+43%	+$155K	﹤0.01%	1798
2020 Q3	$284K	Buy	15,410 +688	+5%	+$13.4K	﹤0.01%	1975
2020 Q2	$300K	Sell	14,722 -5,853	-28%	-$93.2K	﹤0.01%	1960
2020 Q1	$300K	Hold	20,575	–	–	﹤0.01%	1917
2019 Q4	$292K	Buy	20,575 +2,725	+15%	+$34.8K	﹤0.01%	2198
2019 Q3	$207K	Hold	17,850	–	–	﹤0.01%	2233
2019 Q2	$359K	Buy	17,850 +734	+4%	+$14.5K	﹤0.01%	1985
2019 Q1	$387K	Hold	17,116	–	–	﹤0.01%	1918
2018 Q4	$387K	Buy	17,116 +1,073	+7%	+$26.7K	﹤0.01%	1878
2018 Q3	$461K	Hold	16,043	–	–	﹤0.01%	1886
2018 Q2	$437K	Sell	16,043 -1,862	-10%	-$49.6K	﹤0.01%	1906
2018 Q1	$400K	Hold	17,905	–	–	﹤0.01%	1936
2017 Q4	$377K	Hold	17,905	–	–	﹤0.01%	2008
2017 Q3	$446K	Hold	17,905	–	–	﹤0.01%	1937
2017 Q2	$347K	Buy	17,905 +1,891	+12%	+$34.3K	﹤0.01%	2064
2017 Q1	$296K	Hold	16,014	–	–	﹤0.01%	2059
2016 Q4	$303K	Hold	16,014	–	–	﹤0.01%	2048
2016 Q3	$358	Hold	16,014	–	–	﹤0.01%	1931
2016 Q2	$285K	Buy	16,014 +1,148	+8%	+$18.6K	﹤0.01%	2057
2016 Q1	$203K	Hold	14,866	–	–	﹤0.01%	2203
2015 Q4	$287K	Hold	14,866	–	–	﹤0.01%	2075
2015 Q3	$301K	Sell	14,866 -2,373	-14%	-$70.3K	﹤0.01%	2040
2015 Q2	$571K	Buy	17,239 +1,947	+13%	+$53.3K	﹤0.01%	1816
2015 Q1	$366K	Hold	15,292	–	–	﹤0.01%	2115
2014 Q4	$187K	Hold	15,292	–	–	﹤0.01%	2494
2014 Q3	$138K	Hold	15,292	–	–	﹤0.01%	2574
2014 Q2	$180K	Buy	+15,292	New	+$207K	﹤0.01%	2591

Other funds holding TVTX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VOYA Investment Management's TVTX Position: Q1 2026 in Review

VOYA Investment Management increased its Travere Therapeutics (TVTX) stake by 26% in Q1 2026, buying an estimated $1.22M and bringing the position to 196,541 shares worth $5.84M. The position accounts for 0.01% of the portfolio, ranked #779.

VOYA Investment Management first reported a position in TVTX in Q2 2014 and has held it in 48 quarters since. The position peaked at $5.96M in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

VOYA Investment Management held 196,541 shares of Travere Therapeutics worth $5.84M as of Q1 2026.
VOYA Investment Management bought 40,646 Travere Therapeutics shares in Q1 2026, an estimated $1.22M.
Travere Therapeutics made up 0.01% of VOYA Investment Management's portfolio in Q1 2026, its #779 holding.
VOYA Investment Management first reported a position in Travere Therapeutics in Q2 2014 and has held it in 48 quarters since.
VOYA Investment Management's Travere Therapeutics position peaked at $5.96M in Q4 2025.
260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.